A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
Clinical trial NCT05997342 · COMPLETED
Trial details
- NCT number
- NCT05997342
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-16
- Primary completion
- 2025-05-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.